UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2017
OPKO Health, Inc.
(Exact Name of Registrant as Specified in Charter)
| | | | |
| Delaware | | 001-33528 | | 75-2402409 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
4400 Biscayne Blvd
Miami, Florida 33137
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code:(305) 575-4100
Check the appropriate box below if the Form8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant toRule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c)) |
| ITEM 7.01. | Regulation FD Disclosure. |
As previously disclosed, on January 11, 2017 at 9:00 AM (PT), OPKO Health, Inc. (the “Company”) will present at the J.P. Morgan 35th Annual Healthcare Conference. The presentation will be webcast on the Investor Relations page of the Company’s corporate website atwww.opko.com. A copy of the Company’s presentation slides is furnished as Exhibit 99.1 to this Current Report on Form8-K and will also be available the day of the presentation on the OPKO website at www.opko.com under Investor Relations.
The information contained in Item 7.01 to this Current Report on Form8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Act.
| ITEM 9.01. | Financial Statements and Exhibits. |
| | |
Exhibit No. | | Description |
| |
| 99.1 | | The Company’s J.P. Morgan 35th Annual Healthcare Conference presentation slides |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | |
| | | | OPKO Health, Inc. |
| | | |
| Date: January 10, 2017 | | | | By | | /s/ Adam Logal |
| | | | Name: | | Adam Logal |
| | | | Title: | | Senior Vice President, Chief Financial Officer |
Exhibit Index
| | |
Exhibit No. | | Description |
| |
| 99.1 | | The Company’s J.P. Morgan 35th Annual Healthcare Conference presentation slides |
